Rare Disease HTA Target rare disease therapies by offering health technology assessment and value dossier services, leveraging past registry evaluation work to improve outcomes data and support global value dossiers and pricing strategies for niche markets.

Device HTA & Pricing Leverage proven capabilities in health technology assessment for medical devices to deliver cost-effectiveness and budget impact models, pricing strategies, and reimbursement pathway support for device manufacturers.

Integrated HEOR to System Provide integrated HEOR and healthcare system engineering to help clients translate new therapies into care pathways, optimize adoption, and align implementation with budget and access objectives.

Data Analytics Value Use descriptive, predictive, and prescriptive analytics on cloud platforms to generate real world evidence, support market access submissions, and demonstrate value for payer and provider audiences.

Flexible Partnerships As a nimble US-based firm with a small team, offer scalable subcontracting, rapid delivery, and specialized analytics and HEOR engagements that complement larger CROs and pharma partners.